Previous close | 0.6100 |
Open | 0.5400 |
Bid | 0.4000 |
Ask | 0.8500 |
Strike | 75.00 |
Expiry date | 2025-01-17 |
Day's range | 0.5400 - 0.6100 |
Contract range | N/A |
Volume | |
Open interest | 2.41k |
The European Commission approves AbbVie's (ABBV) Tepkinly (epcoritamab) for DLBCL. FDA approves Lilly's (LLY) Jardiance for chronic kidney disease.
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Oracle, AbbVie, Lowe's Companies, Ecolab and Motorola Solutions are part of the Zacks top Analyst Blog .